Constitutive expression of CD26/dipeptidylpeptidase IV on peripheral blood B lymphocytes of patients with B chronic lymphocytic leukaemia

British Journal of Cancer

Volumn 79, Issue 7-8, 1999, Pages 1042-1048

  Bauvois, B ^a   De Meester, I ^b   Dumont, J ^a   Rouillard, D ^a   Zhao, H X ^a   Bosmans, E ^c  

^a INSTITUT CURIE   (France)

^b UNIVERSITY OF ANTWERP   (Belgium)

^c Eurogenetics   (Belgium)

Author keywords

B cell activation; B CLL; CD26 antigen; Dipeptidylpeptidase IV

Indexed keywords

CD20 ANTIGEN; CD23 ANTIGEN; DIPEPTIDYL PEPTIDASE IV; INTERLEUKIN 4;

ARTICLE; B LYMPHOCYTE; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STAPHYLOCOCCUS AUREUS; TRANSCRIPTION INITIATION;

ADULT; ANTIGENS, CD26; ANTIGENS, SURFACE; B-LYMPHOCYTES; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; LEUKEMIA, B-CELL, CHRONIC; POLYMERASE CHAIN REACTION;

EID: 0033060417     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6690167     Document Type: Article

References (32)

1. Abbott CA, Baker E, Sutherland GR and McCaughan GW (1994) Genomic organisation, exact localization, and tissue expression of the human CD26 (dipeptidyl peptidase IV) gene. Immunogenetics 40: 331-338
2. Andrews C, Crockard AD, San Miguel JF and Catovsky D (1985) Dipeptidylaminopeptidase IV (DAPIV) in B- and T-leukemias. Clin Lab Haematol 7: 359-368
3. Bauvois B (1997) Molecular and functional aspects of human myelomonocytic ectopeptidases. In Cell Surface Peptidases in Health and Disease, Kenny AJ and Boustead CM (eds), pp. 341-350. Bios Ltd: Oxford
4. Bauvois B, Sancéau J and Wietzerbin J (1992) Human U937 cell surface peptidase activities: characterization and degradative effect on tumour necrosis factor-α. Eur J Immunol 22: 923-930
5. Bauvois B, Van Weyenbergh J, Rouillard D and Wietzerbin J (1996) TGF-β1-stimulated adhesion of human mononuclear phagocytes to fibronectin and laminin is abolished by IFN-γ: dependence on α5β1 and β2 integrins. Exp Cell Res 222: 209-217
6. Bühling F, Junker U, Reinhold D, Neubert K, Jäger L and Ansorge S (1994) Functional role of CD26 on human B lymphocytes. Immunol Lett 45: 47-51
7. Bylinkina VS, Lokshina LA, Samojlova RS, Lubkova ON, Gureeva TA and Golubeva NV (1992) Dipeptidylpeptidase IV in human leukemic B- and T-cells. Biochem Int 28: 31-39
8. Carbone A, Cozzi M, Gloghini A and Pinto A (1994) CD26/dipeptidylpeptidase IV expression in human lymphomas is restricted to CD30-positive anaplastic large cells and a subset of T-cell non Hodgkin's lymphomas. Hum Pathol 25: 1360-1365
9. Chomeczynski P and Sacchi N (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156-159
10. De Meester I, Scharpé S, Vanham G, Bosmans E, Heylingen H, Vanhoof G and Corte G (1993) Antibody binding profile of purified and cell-bound CD26. Designation of BT5/9 and TA5.9 to the CD26 cluster. Immunobiology 188: 145-158
11. De Meester I, Korom S, Belyaev A, Stadlbauer T, Goossens F, Haemers A, Kupiec-Weglinski JW and Scharpé S (1997) Inhibition of DPPIV/CD26 enzymatic activity abrogates accelerated rejection of rat cardiac allografts. Immunol Lett 56:487-491
12. Duke-Cohan JS, Morimoto C, Rocker JA and Schlossman SF (1996) Serum high molecular weight dipeptidyl peptidase IV (CD26) is similar to a novel antigen DPPT-L released from activated T cells. J Immunol 156: 1714-1721
13. + cells in the peripheral blood and thyroid tissue of patients with Grave's disease. J Immunol 142: 4233-4240
14. Feller AC, Parwaresch R and Lennert K (1983) Subtyping of chronic lymphocytic leukemia of T-type by dipeptidylpeptidase IV (DAP IV), monoclonal antibodies and Fc-receptors. Cancer 52: 1609-1612
15. Fleisher B (1994) CD26: a surface protease involved in T-cell activation. Immunol Today 15: 180-184
16. Flentke GR, Munoz E, Huber TB, Plaut AG, Kettner CA and Bachovchin WW (1991) Inhibition of dipeptidyl aminopeptidase IV (DP-IV) by Xaa-boroPro dipeptides and use of these inhibitors to examine the role of DP-IV in T-cell function. Proc Natl Acad Sci USA 88: 1556-1559
17. Hafler DA, Fox DA, Manning ME, Schlossman SF, Reinherz EL and Weiner HL (1985) In vivo activated T lymphocytes in the peripheral blood and cerebrospinal fluid of patients with multiple sclerosis. New Engl J Med 312: 1405-14011
18. Hegen M, Kameoka J, Dong RP, Schlossman SF and Morimoto C (1997) Cross-linking of CD26 by antibody induces tyrosine phosphorylation and activation of mitogen-activated protein kinase. Immunology 90: 257-264
19. Invernizzi R, Bertolino G, Girino M, Perseghin P, Michiensi M and Nano R (1985) Cytochemistry of dipeptidylpeptidase IV and II in normal and neoplastic lymphoid cells. Blut 50: 277-283
20. Jacotot E, Callebaut C, Blanco J, Krust B, Neubert K, Barth A and Hovanessian A (1996) Dipeptidylpeptidase IV-β, a novel form of cell surface expressed protein with dipeptidyl-peptidase IV activity. Eur J Biochem 239: 248-258
21. Khalaf MR, Aqel NM and Hayhoe FGJ (1987) Histochemistry of dipeptidylaminopeptidase (DAP) II and IV in reactive lymphoid tissues and malignant lymphoma. J Clin Pathol 40: 480-485
22. Kolb JP, Genot E, Poggioli J, Abadie A, Sarfati M, Delespesse G and Dugas B (1991) Transduction through CD23: different signalling pathways in human B cells and monocytes. Monogr Allergy 29: 135-141
23. Kondo S, Kotani T, Tamura K, Aratake Y, Uno H, Tsubuchi H, Inoue S, Niho Y and Ohtaki S (1996) Expression of CD26/dipeptidylpeptidase IV in adult T cell leukemia/lymphoma (ATLL). Leuk Res 20: 357-363
24. Letarte M, Greaves A and Ishii E (1997) The biological functions of CD10/endopeptidase 24.11 in normal and malignant cells. In Cell Surface Peptidases in Health and Disease, Kenny AJ and Boustead CM (eds), pp. 329-337. Bios Ltd: Oxford
25. Nakao H, Eguchi K, Kawakami A and Nagataki S (1989) Increment of Ta1 positive cells in peripheral blood from patients with rheumatoid arthritis. J Rheumat 16: 7-10
26. Schön E, Jahn S, Kiessig T, Demuth HU, Neubert K, Barth A, Von Baehr R and Ansörge S (1987) The role of dipeptidylpeptidase IV in human T lymphocyte activation: inhibitors and antibodies against dipeptidylpeptidase IV suppress lymphocyte proliferation and immunoglobulin synthesis in vitro. Eur J Immunol 17: 1821-1826
27. Scott CS, Stark AN, Minowada J and Drexler HG (1988) Quantitative and qualitative studies of leukemic cell dipeptidyl peptidase II and IV. Leuk Res 12: 129-134
28. Srivastava MD and Bhargava AK (1986) Expression of dipeptidylaminopeptidase-IV in some human T and B cell lines. Acta Haematol 76: 25-28
29. Tanaka T, Umeki K, Yamamoto Y, Akamoto F, Noguchi and Ohtaki, S (1995) CD26 (dipeptidylpeptidase IV/DPP IV) as a novel molecular marker for differentiated thyroid carcinoma. Int J Cancer 64: 326-331
30. Uematsu T, Urade M, Yamaoka M and Yoshioha M (1996) Reduced expression of dipeptidylpeptidase (DPP) IV in peripheral blood T lymphocytes of oral cancer patients. J Oral Pathol Med 25: 507-512
31. Vanham G, Kestens L, De Meester I, Vingerhoets J, Penne G, Vanhoof G, Scharpé S, Heyligen H, Bosmans E, Ceuppens JL and Gigase (1993) Decreased expression of the memory marker CD26 on both CD4+ and CD8+ T lymphocytes of HIV-infected subjects. J Acquir Immune Defic Syndr 6: 749-757
32. Yokotani N, Doi K, Wenthold J and Wada K (1993) Non-conservation of a catalytic residue in a dipeptidyl aminopeptidase IV-related protein encoded by a gene on human chromosome 7. Hum Mol Genet 2: 1037-1039